Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALZN | Common Stock | Other | $1.4M | +933K | +9.24% | $1.50 | 11M | Nov 11, 2022 | By Ault Lending, LLC | F1, F2 |
holding | ALZN | Common Stock | 2.5M | Nov 11, 2022 | Direct | ||||||
holding | ALZN | Common Stock | 14.9M | Nov 11, 2022 | By Ault Life Sciences, Inc. | F3 | |||||
holding | ALZN | Common Stock | 10M | Nov 11, 2022 | By Ault Life Sciences Fund, LLC | F4 | |||||
holding | ALZN | Common Stock | 325K | Nov 11, 2022 | By Ault Alpha LP | F5 |
Id | Content |
---|---|
F1 | In November 2022, the Issuer entered into an agreement for marketing and brand development services with BitNile Holdings, Inc. ("BH"), pursuant to which BH agreed to provide advertising, marketing, consulting, creative and/or digital services for the Issuer, for a fee of $1.4 million. The Issuer had the right, in its election, to pay the fee in cash or shares of common stock, with the shares to be valued at $1.50 per share. On November 11, 2022, the Issuer elected to pay the fee in Shares, and issued 933,334 shares to Ault Lending, LLC, ("Ault Lending") a wholly owned subsidiary of BH. |
F2 | Ault Lending is a wholly-owned subsidiary of BH. Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |
F3 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. |
F4 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. |
F5 | Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP. |